cyclohexanol has been researched along with Schizophrenia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giuffrida, A; Martinez, AA; Seillier, A | 1 |
| Carrasco, GA; Franklin, JM | 1 |
| Namdari, B | 1 |
| Giuffrida, A; Seillier, A | 1 |
| Hardy-Baylé, MC; Passerieux, C | 1 |
| Arnold, JC; Boucher, AA; Huang, X; Hunt, GE; Karl, T; McGregor, IS; Micheau, J | 1 |
| Clarke, G; Clarke, N; Cryan, JF; Desbonnet, L; Dinan, TG; Gogos, JA; Karayiorgou, M; O'Leary, C; O'Tuathaigh, CM; Petit, E; Tighe, O; Waddington, JL; Walsh, J | 1 |
| Bowers, L; Callaghan, P; Clark, N; Evers, C | 1 |
| Mazeh, D; Melamed, Y; Saraf, R; Shahal, B | 1 |
| Grignon, S; Trottier, M | 1 |
| Eloranta, A; Hallikainen, T; Repo-Tiihonen, E; Tiihonen, J | 1 |
| Chen, Z; Dyck, L; Haimanot, S; He, J; Li, X; Li, XM; Xu, H | 1 |
| Deng, C; Huang, XF; Newell, KA | 1 |
| Falsig, J; Geist, MA; Leist, M; Podhorna, J; Volbracht, C | 1 |
| Elizur, A; Mazeh, D; Melamed, Y | 1 |
| Bradbury, R; Copolov, D; Dean, B; Scarr, E; Sundram, S | 1 |
1 review(s) available for cyclohexanol and Schizophrenia
| Article | Year |
|---|---|
[Mood disorders].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
2 trial(s) available for cyclohexanol and Schizophrenia
| Article | Year |
|---|---|
Venlafaxine for the treatment of depressive episode during the course of schizophrenia.
Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Venlafaxine Hydrochloride | 2004 |
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clozapine; Cyclohexanols; Depression; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 2005 |
13 other study(ies) available for cyclohexanol and Schizophrenia
| Article | Year |
|---|---|
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Topics: Amidohydrolases; Amygdala; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Carbamates; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Male; Phencyclidine; Piperidines; Polyunsaturated Alkamides; Prefrontal Cortex; Pyrazoles; Quinazolinones; Rats; Receptor, Cannabinoid, CB1; Receptor, Cholecystokinin B; Rimonabant; Schizophrenia; Social Behavior | 2013 |
G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.
Topics: Analgesics; Animals; Anxiety; Arrestins; beta-Arrestin 2; beta-Arrestins; Calcium; Cell Culture Techniques; Cyclohexanols; G-Protein-Coupled Receptor Kinase 5; Humans; Lentivirus; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 3; Models, Biological; Nerve Tissue Proteins; Neurons; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptor, Serotonin, 5-HT2A; RNA Interference; Schizophrenia; Up-Regulation | 2013 |
Venlafaxine abuse in a patient with schizophrenia and prior history of substance dependence: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Drug-Seeking Behavior; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Venlafaxine Hydrochloride | 2013 |
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
Topics: Analysis of Variance; Animals; Cannabinoid Receptor Modulators; Cyclohexanols; Discrimination, Psychological; Disease Models, Animal; Endocannabinoids; Excitatory Amino Acid Antagonists; Exploratory Behavior; Male; Odorants; Phencyclidine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Social Behavior Disorders; Social Perception | 2016 |
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dronabinol; Drug Tolerance; Exploratory Behavior; Genotype; Heterozygote; Male; Mice; Mice, Mutant Strains; Motor Activity; Neuregulin-1; Proto-Oncogene Proteins c-fos; Psychotropic Drugs; Reflex, Startle; Schizophrenia | 2011 |
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
Topics: Alleles; Animals; Anxiety; Benzophenones; Benzoxazines; Biogenic Monoamines; Cannabinoid Receptor Agonists; Cannabinoids; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Cyclohexanols; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Nitrophenols; Pain Measurement; Phenotype; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Social Behavior; Swimming; Tolcapone | 2012 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride | 2004 |
Capgras syndrome in the modern era: self misidentification on an ID picture.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Olanzapine; Recurrence; Schizophrenia; Self Concept; Social Identification; Venlafaxine Hydrochloride; Visual Perception | 2005 |
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Proliferation; Chronic Disease; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hippocampus; Neuronal Plasticity; Neurons; Quetiapine Fumarate; Rats; Restraint, Physical; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Stem Cells; Stress, Psychological; Venlafaxine Hydrochloride | 2006 |
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.
Topics: Adult; Aged; Autoradiography; Case-Control Studies; Cyclohexanols; Gyrus Cinguli; Humans; Male; Middle Aged; Postmortem Changes; Receptors, Cannabinoid; Schizophrenia; Statistics, Nonparametric; Tritium | 2006 |
Wide spectrum modulation by KP-544 in models relevant for neuronal survival.
Topics: Animals; Astrocytes; Cell Death; Cell Survival; Cerebellum; Cyclohexanols; Disease Models, Animal; Drug Synergism; Female; Male; Methylazoxymethanol Acetate; Nerve Growth Factor; Neurites; Neurons; Neuroprotective Agents; Neurotoxins; PC12 Cells; Pregnancy; Pyrimidines; Rats; Schizophrenia | 2007 |
Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Resistance; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 1999 |
Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.
Topics: Brain; Cannabinoids; Cannabis; Cyclohexanols; Dronabinol; Humans; In Vitro Techniques; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Schizophrenia; Substance-Related Disorders | 2001 |